The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
The global Antivirals market was valued at US$ 44620 million in 2023 and is anticipated to reach US$ 62600 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antivirals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antivirals.
Report Scope
The Antivirals market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antivirals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antivirals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy’s
Segment by Type
Generic
Branded
Segment by Application
HIV
Hepatitis
HSV
Influenza
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antivirals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antivirals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
The global Antivirals market was valued at US$ 44620 million in 2023 and is anticipated to reach US$ 62600 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antivirals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antivirals.
Report Scope
The Antivirals market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antivirals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antivirals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy’s
Segment by Type
Generic
Branded
Segment by Application
HIV
Hepatitis
HSV
Influenza
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antivirals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antivirals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antivirals Market Overview
1.1 Product Overview and Scope of Antivirals
1.2 Antivirals Segment by Type
1.2.1 Global Antivirals Market Value Comparison by Type (2024-2030)
1.2.2 Generic
1.2.3 Branded
1.3 Antivirals Segment by Application
1.3.1 Global Antivirals Market Value by Application: (2024-2030)
1.3.2 HIV
1.3.3 Hepatitis
1.3.4 HSV
1.3.5 Influenza
1.4 Global Antivirals Market Size Estimates and Forecasts
1.4.1 Global Antivirals Revenue 2019-2030
1.4.2 Global Antivirals Sales 2019-2030
1.4.3 Global Antivirals Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antivirals Market Competition by Manufacturers
2.1 Global Antivirals Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antivirals Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antivirals Average Price by Manufacturers (2019-2024)
2.4 Global Antivirals Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antivirals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antivirals, Product Type & Application
2.7 Antivirals Market Competitive Situation and Trends
2.7.1 Antivirals Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antivirals Players Market Share by Revenue
2.7.3 Global Antivirals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antivirals Retrospective Market Scenario by Region
3.1 Global Antivirals Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antivirals Global Antivirals Sales by Region: 2019-2030
3.2.1 Global Antivirals Sales by Region: 2019-2024
3.2.2 Global Antivirals Sales by Region: 2025-2030
3.3 Global Antivirals Global Antivirals Revenue by Region: 2019-2030
3.3.1 Global Antivirals Revenue by Region: 2019-2024
3.3.2 Global Antivirals Revenue by Region: 2025-2030
3.4 North America Antivirals Market Facts & Figures by Country
3.4.1 North America Antivirals Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antivirals Sales by Country (2019-2030)
3.4.3 North America Antivirals Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antivirals Market Facts & Figures by Country
3.5.1 Europe Antivirals Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antivirals Sales by Country (2019-2030)
3.5.3 Europe Antivirals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antivirals Market Facts & Figures by Country
3.6.1 Asia Pacific Antivirals Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antivirals Sales by Country (2019-2030)
3.6.3 Asia Pacific Antivirals Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antivirals Market Facts & Figures by Country
3.7.1 Latin America Antivirals Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antivirals Sales by Country (2019-2030)
3.7.3 Latin America Antivirals Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antivirals Market Facts & Figures by Country
3.8.1 Middle East and Africa Antivirals Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antivirals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antivirals Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antivirals Sales by Type (2019-2030)
4.1.1 Global Antivirals Sales by Type (2019-2024)
4.1.2 Global Antivirals Sales by Type (2025-2030)
4.1.3 Global Antivirals Sales Market Share by Type (2019-2030)
4.2 Global Antivirals Revenue by Type (2019-2030)
4.2.1 Global Antivirals Revenue by Type (2019-2024)
4.2.2 Global Antivirals Revenue by Type (2025-2030)
4.2.3 Global Antivirals Revenue Market Share by Type (2019-2030)
4.3 Global Antivirals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antivirals Sales by Application (2019-2030)
5.1.1 Global Antivirals Sales by Application (2019-2024)
5.1.2 Global Antivirals Sales by Application (2025-2030)
5.1.3 Global Antivirals Sales Market Share by Application (2019-2030)
5.2 Global Antivirals Revenue by Application (2019-2030)
5.2.1 Global Antivirals Revenue by Application (2019-2024)
5.2.2 Global Antivirals Revenue by Application (2025-2030)
5.2.3 Global Antivirals Revenue Market Share by Application (2019-2030)
5.3 Global Antivirals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Antivirals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Antivirals Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Antivirals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Antivirals Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Teva Pharmaceutical Industries
6.3.1 Teva Pharmaceutical Industries Corporation Information
6.3.2 Teva Pharmaceutical Industries Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Antivirals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Pharmaceutical Industries Antivirals Product Portfolio
6.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Antivirals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSK Antivirals Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Antivirals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Antivirals Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Gilead Sciences
6.6.1 Gilead Sciences Corporation Information
6.6.2 Gilead Sciences Description and Business Overview
6.6.3 Gilead Sciences Antivirals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Gilead Sciences Antivirals Product Portfolio
6.6.5 Gilead Sciences Recent Developments/Updates
6.7 F. Hoffmann-La Roche
6.6.1 F. Hoffmann-La Roche Corporation Information
6.6.2 F. Hoffmann-La Roche Description and Business Overview
6.6.3 F. Hoffmann-La Roche Antivirals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 F. Hoffmann-La Roche Antivirals Product Portfolio
6.7.5 F. Hoffmann-La Roche Recent Developments/Updates
6.8 Bristol-Myers-Squibb
6.8.1 Bristol-Myers-Squibb Corporation Information
6.8.2 Bristol-Myers-Squibb Description and Business Overview
6.8.3 Bristol-Myers-Squibb Antivirals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bristol-Myers-Squibb Antivirals Product Portfolio
6.8.5 Bristol-Myers-Squibb Recent Developments/Updates
6.9 AbbVie
6.9.1 AbbVie Corporation Information
6.9.2 AbbVie Description and Business Overview
6.9.3 AbbVie Antivirals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AbbVie Antivirals Product Portfolio
6.9.5 AbbVie Recent Developments/Updates
6.10 Aurobindo Pharma
6.10.1 Aurobindo Pharma Corporation Information
6.10.2 Aurobindo Pharma Description and Business Overview
6.10.3 Aurobindo Pharma Antivirals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Aurobindo Pharma Antivirals Product Portfolio
6.10.5 Aurobindo Pharma Recent Developments/Updates
6.11 Cipla
6.11.1 Cipla Corporation Information
6.11.2 Cipla Antivirals Description and Business Overview
6.11.3 Cipla Antivirals Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cipla Antivirals Product Portfolio
6.11.5 Cipla Recent Developments/Updates
6.12 Dr Reddy’s
6.12.1 Dr Reddy’s Corporation Information
6.12.2 Dr Reddy’s Antivirals Description and Business Overview
6.12.3 Dr Reddy’s Antivirals Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Dr Reddy’s Antivirals Product Portfolio
6.12.5 Dr Reddy’s Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antivirals Industry Chain Analysis
7.2 Antivirals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antivirals Production Mode & Process
7.4 Antivirals Sales and Marketing
7.4.1 Antivirals Sales Channels
7.4.2 Antivirals Distributors
7.5 Antivirals Customers
8 Antivirals Market Dynamics
8.1 Antivirals Industry Trends
8.2 Antivirals Market Drivers
8.3 Antivirals Market Challenges
8.4 Antivirals Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Antivirals Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Antivirals Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Antivirals Market Competitive Situation by Manufacturers in 2023
Table 4. Global Antivirals Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global Antivirals Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Antivirals Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Antivirals Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Antivirals Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Antivirals, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antivirals, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antivirals, Product Type & Application
Table 12. Global Key Manufacturers of Antivirals, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antivirals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivirals as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antivirals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Antivirals Sales by Region (2019-2024) & (K MT)
Table 18. Global Antivirals Sales Market Share by Region (2019-2024)
Table 19. Global Antivirals Sales by Region (2025-2030) & (K MT)
Table 20. Global Antivirals Sales Market Share by Region (2025-2030)
Table 21. Global Antivirals Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Antivirals Revenue Market Share by Region (2019-2024)
Table 23. Global Antivirals Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Antivirals Revenue Market Share by Region (2025-2030)
Table 25. North America Antivirals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Antivirals Sales by Country (2019-2024) & (K MT)
Table 27. North America Antivirals Sales by Country (2025-2030) & (K MT)
Table 28. North America Antivirals Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Antivirals Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Antivirals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Antivirals Sales by Country (2019-2024) & (K MT)
Table 32. Europe Antivirals Sales by Country (2025-2030) & (K MT)
Table 33. Europe Antivirals Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Antivirals Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Antivirals Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Antivirals Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific Antivirals Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific Antivirals Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Antivirals Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Antivirals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Antivirals Sales by Country (2019-2024) & (K MT)
Table 42. Latin America Antivirals Sales by Country (2025-2030) & (K MT)
Table 43. Latin America Antivirals Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Antivirals Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Antivirals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Antivirals Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa Antivirals Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa Antivirals Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Antivirals Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Antivirals Sales (K MT) by Type (2019-2024)
Table 51. Global Antivirals Sales (K MT) by Type (2025-2030)
Table 52. Global Antivirals Sales Market Share by Type (2019-2024)
Table 53. Global Antivirals Sales Market Share by Type (2025-2030)
Table 54. Global Antivirals Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Antivirals Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Antivirals Revenue Market Share by Type (2019-2024)
Table 57. Global Antivirals Revenue Market Share by Type (2025-2030)
Table 58. Global Antivirals Price (USD/MT) by Type (2019-2024)
Table 59. Global Antivirals Price (USD/MT) by Type (2025-2030)
Table 60. Global Antivirals Sales (K MT) by Application (2019-2024)
Table 61. Global Antivirals Sales (K MT) by Application (2025-2030)
Table 62. Global Antivirals Sales Market Share by Application (2019-2024)
Table 63. Global Antivirals Sales Market Share by Application (2025-2030)
Table 64. Global Antivirals Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Antivirals Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Antivirals Revenue Market Share by Application (2019-2024)
Table 67. Global Antivirals Revenue Market Share by Application (2025-2030)
Table 68. Global Antivirals Price (USD/MT) by Application (2019-2024)
Table 69. Global Antivirals Price (USD/MT) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Merck Antivirals Product
Table 74. Merck Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Johnson & Johnson Antivirals Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Teva Pharmaceutical Industries Corporation Information
Table 81. Teva Pharmaceutical Industries Description and Business Overview
Table 82. Teva Pharmaceutical Industries Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Teva Pharmaceutical Industries Antivirals Product
Table 84. Teva Pharmaceutical Industries Recent Developments/Updates
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. GSK Antivirals Product
Table 89. GSK Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Mylan Antivirals Product
Table 94. Mylan Recent Developments/Updates
Table 95. Gilead Sciences Corporation Information
Table 96. Gilead Sciences Description and Business Overview
Table 97. Gilead Sciences Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Gilead Sciences Antivirals Product
Table 99. Gilead Sciences Recent Developments/Updates
Table 100. F. Hoffmann-La Roche Corporation Information
Table 101. F. Hoffmann-La Roche Description and Business Overview
Table 102. F. Hoffmann-La Roche Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. F. Hoffmann-La Roche Antivirals Product
Table 104. F. Hoffmann-La Roche Recent Developments/Updates
Table 105. Bristol-Myers-Squibb Corporation Information
Table 106. Bristol-Myers-Squibb Description and Business Overview
Table 107. Bristol-Myers-Squibb Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Bristol-Myers-Squibb Antivirals Product
Table 109. Bristol-Myers-Squibb Recent Developments/Updates
Table 110. AbbVie Corporation Information
Table 111. AbbVie Description and Business Overview
Table 112. AbbVie Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. AbbVie Antivirals Product
Table 114. AbbVie Recent Developments/Updates
Table 115. Aurobindo Pharma Corporation Information
Table 116. Aurobindo Pharma Description and Business Overview
Table 117. Aurobindo Pharma Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Aurobindo Pharma Antivirals Product
Table 119. Aurobindo Pharma Recent Developments/Updates
Table 120. Cipla Corporation Information
Table 121. Cipla Description and Business Overview
Table 122. Cipla Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. Cipla Antivirals Product
Table 124. Cipla Recent Developments/Updates
Table 125. Dr Reddy’s Corporation Information
Table 126. Dr Reddy’s Description and Business Overview
Table 127. Dr Reddy’s Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 128. Dr Reddy’s Antivirals Product
Table 129. Dr Reddy’s Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Antivirals Distributors List
Table 133. Antivirals Customers List
Table 134. Antivirals Market Trends
Table 135. Antivirals Market Drivers
Table 136. Antivirals Market Challenges
Table 137. Antivirals Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antivirals
Figure 2. Global Antivirals Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Antivirals Market Share by Type in 2023 & 2030
Figure 4. Generic Product Picture
Figure 5. Branded Product Picture
Figure 6. Global Antivirals Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Antivirals Market Share by Application in 2023 & 2030
Figure 8. HIV
Figure 9. Hepatitis
Figure 10. HSV
Figure 11. Influenza
Figure 12. Global Antivirals Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Antivirals Market Size (2019-2030) & (US$ Million)
Figure 14. Global Antivirals Sales (2019-2030) & (K MT)
Figure 15. Global Antivirals Average Price (USD/MT) & (2019-2030)
Figure 16. Antivirals Report Years Considered
Figure 17. Antivirals Sales Share by Manufacturers in 2023
Figure 18. Global Antivirals Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Antivirals Players: Market Share by Revenue in 2023
Figure 20. Antivirals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Antivirals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Antivirals Sales Market Share by Country (2019-2030)
Figure 23. North America Antivirals Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Antivirals Sales Market Share by Country (2019-2030)
Figure 27. Europe Antivirals Revenue Market Share by Country (2019-2030)
Figure 28. Germany Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Antivirals Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Antivirals Revenue Market Share by Region (2019-2030)
Figure 35. China Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Antivirals Sales Market Share by Country (2019-2030)
Figure 46. Latin America Antivirals Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Antivirals Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Antivirals Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Antivirals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Antivirals by Type (2019-2030)
Figure 56. Global Revenue Market Share of Antivirals by Type (2019-2030)
Figure 57. Global Antivirals Price (USD/MT) by Type (2019-2030)
Figure 58. Global Sales Market Share of Antivirals by Application (2019-2030)
Figure 59. Global Revenue Market Share of Antivirals by Application (2019-2030)
Figure 60. Global Antivirals Price (USD/MT) by Application (2019-2030)
Figure 61. Antivirals Value Chain
Figure 62. Antivirals Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
